Seer to Report Fourth Quarter and Full Year 2024 Financial Results on February 27, 2025
Rhea-AI Summary
Seer (Nasdaq: SEER) has announced it will release its fourth quarter and full year 2024 financial results on Thursday, February 27, 2025. The life sciences company, which specializes in proteomics platform technology, will host a conference call and webcast at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time on the same day. Investors can access the live webcast through the Investor section of Seer's website at investor.seer.bio, where an archived replay will also be available after the event.
Positive
- None.
Negative
- None.
News Market Reaction – SEER
On the day this news was published, SEER declined NaN%, reflecting a moderate negative market reaction.
Data tracked by StockTitan Argus on the day of publication.
REDWOOD CITY, Calif., Feb. 13, 2025 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER), a leading life sciences company commercializing a disruptive new platform for proteomics, today announced that it will report financial results for the fourth quarter and full year 2024 on Thursday, February 27, 2025. Company management will be webcasting a conference call beginning at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time.
Live audio of the webcast will be available on the Investor section of Seer’s website at investor.seer.bio. An archived replay will be available on the company’s website following the event.
About Seer
Seer is a life sciences company developing transformative products that open a new gateway to the proteome. Seer’s Proteograph™ Product Suite is an integrated solution that includes proprietary engineered nanoparticles, consumables, automation instrumentation and software to perform deep, unbiased proteomic analysis at scale in a matter of hours. Seer designed the Proteograph workflow to be efficient and easy to use, leveraging widely adopted laboratory instrumentation to provide a decentralized solution that can be incorporated by nearly any lab. Seer’s Proteograph Product Suite is for research use only and is not intended for diagnostic procedures. For more information, please visit www.seer.bio.
Media Contact:
Patrick Schmidt
pr@seer.bio
Investor Contact:
Carrie Mendivil
investor@seer.bio
FAQ
When will Seer (SEER) release its Q4 and full year 2024 earnings?
What time is Seer's Q4 2024 earnings call?
Where can I listen to Seer's Q4 2024 earnings webcast?
Will Seer's Q4 2024 earnings call be available for replay?
